MedPath

Butamben

Generic Name
Butamben
Brand Names
Cetacaine, One Touch Reformulated Apr 2009
Drug Type
Small Molecule
Chemical Formula
C11H15NO2
CAS Number
94-25-7
Unique Ingredient Identifier
EFW857872Q

Overview

Butamben is a local anesthetic in the form of n-butyl-p-aminobenzoate. Its structure corresponds to the standard molecule of a hydrophilic and hydrophobic domain separated by an intermediate ester found in most of the local anesthetics. Due to its very low water solubility, butamben is considered to be suitable only for topical anesthesia. The FDA removed all parenteral butamben products from the market, possibly due to the poor solubility of this drug.

Background

Butamben is a local anesthetic in the form of n-butyl-p-aminobenzoate. Its structure corresponds to the standard molecule of a hydrophilic and hydrophobic domain separated by an intermediate ester found in most of the local anesthetics. Due to its very low water solubility, butamben is considered to be suitable only for topical anesthesia. The FDA removed all parenteral butamben products from the market, possibly due to the poor solubility of this drug.

Indication

Butamben was indicated for the treatment of chronic pain due to its long-duration effect. It is also indicated as a surface anesthetic for skin a mucous membrane and for the relief of pain and pruritus associated with anorectal disorders.

Associated Conditions

No associated conditions information available.

Clinical Trials

No clinical trials found for this drug

FDA Approved Products

Cetacaine Anesthetic
Manufacturer:Cetylite Industries, Inc.
Route:TOPICAL
Strength:0.004 g in 0.2 g
Approved: 2023/05/11
NDC:10223-0202
Cetacaine Anesthetic
Manufacturer:Cetylite Industries, Inc.
Route:TOPICAL
Strength:0.004 g in 0.2 g
Approved: 2023/05/11
NDC:10223-0225
Cetacaine Anesthetic
Manufacturer:Cetylite Industries, Inc.
Route:TOPICAL
Strength:0.004 g in 0.2 g
Approved: 2023/05/11
NDC:10223-0226
Cetacaine Topical Anesthetic
Manufacturer:Cetylite Industries, Inc.
Route:TOPICAL
Strength:0.004 g in 0.2 g
Approved: 2022/01/17
NDC:10223-0217
Cetacaine Topical Anesthetic
Manufacturer:Cetylite Industries, Inc.
Route:TOPICAL
Strength:0.004 g in 0.2 g
Approved: 2022/01/17
NDC:10223-0221

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath